SCHEMBL9458948

SCHEMBL9458948

Cc1ccccc1CC(CS)NC(=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 1/20 0.58
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
ECE1 P42892 1/20 0.46
PPARG P37231 1/20 0.44
MME P08473 2/20 0.42
HTT P42858 2/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
ROCK2 O75116 1/20 0.41
RPS6KA5 O75582 1/20 0.41
RPS6KA4 O75676 1/20 0.41
PRKACA P17612 1/20 0.41
MAPK1 P28482 1/20 0.41
GSK3A P49840 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7357606 0.89 CTRB1 (0.54) CTRB1ALDH1A1HPGDECE1MME
SCHEMBL9486724 0.89 CTRB1 (0.54) CTRB1ALDH1A1HPGDECE1MME
SCHEMBL9458824 0.87 CTRB1 (0.49) CTRB1ALDH1A1HPGDECE1PPARG
SCHEMBL9459228 0.86 CTRB1 (0.53) CTRB1ALDH1A1HPGDECE1MEN1
SCHEMBL9459389 0.84 HTT (0.57) CTRB1ALDH1A1HPGDECE1MME
SCHEMBL9322253 0.75 CTRB1 (0.53) CTRB1ECE1PPARGMMEKDM4E
SCHEMBL11493557 0.74 CTRB1 (1.00) CTRB1ECE1MMEROCK2RPS6KA5
SCHEMBL9727410 0.73 LMNA (0.45) CTRB1ECE1PPARGMMELMNA
SCHEMBL9727406 0.73 LMNA (0.45) CTRB1ECE1PPARGMMELMNA
SCHEMBL9458917 0.71 HTT (0.42) ALDH1A1HPGDPPARGMMEHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5232920-A For treating hypertension and congestive heart failure in mammals SCHERING CORPORATION (US) 1993-08-03 US claimed
US-5232920-A For treating hypertension and congestive heart failure in mammals SCHERING CORPORATION (US) 1993-08-03 US disclosed